Benidipine
CARDIOVASCULAR SYSTEM
Also known as: benidipine HCl, benidipine hydrochloride, coniel
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Benidipine is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1991. DrugCentral lists 2 molecular targets, including CACNA1H and CACNA1D|CACNA1C.
- Molecular targets: CACNA1H and CACNA1D|CACNA1C (2 listed in DrugCentral).
- ATC code: C08CA15 (Dihydropyridine derivatives).
- Molecular formula: C28H31N3O6; molecular weight 505.57 g/mol.
Mechanism & targets
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Voltage-dependent T-type calcium channel subunit alpha-1H | CACNA1H | blocker | IC50 6.84 |
| Voltage-gated L-type calcium channel | CACNA1D|CACNA1C | blocker | IC50 5.31 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1991-01-01 | YEAR INTRODUCED | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C08CA15 | CARDIOVASCULAR SYSTEM › CALCIUM CHANNEL BLOCKERS › SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS › Dihydropyridine derivatives |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Cerebral infarction | 141.7 |
| Renal impairment | 100.7 |
| Interstitial lung disease | 87.0 |
| Inappropriate antidiuretic hormone secretion | 69.7 |
| Cardiac failure | 68.9 |
| Hepatic function abnormal | 67.9 |
| Altered state of consciousness | 63.6 |
| Prinzmetal angina | 60.5 |
| Platelet count decreased | 46.8 |
| Blood pressure decreased | 43.5 |
| Drug interaction | 36.4 |
| Colon cancer | 31.0 |
Chemical structure
| Molecular formula | C28H31N3O6 |
|---|---|
| Molecular weight | 505.57 g/mol |
| CAS number | 105979-17-7 |
| InChIKey | QZVNQOLPLYWLHQ-GEPVFLLWSA-N |
| PubChem CID | 656668 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Benidipine work?
Its molecular targets in DrugCentral include CACNA1H (blocker) and CACNA1D|CACNA1C (blocker).
When was Benidipine first approved?
Benidipine was first approved by the YEAR INTRODUCED in 1991.
What is the chemical formula of Benidipine?
Benidipine has the molecular formula C28H31N3O6 and a molecular weight of 505.57 g/mol.
Browse: all drugs starting with B · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 3880 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2074972 — compound record and bioactivity
- PubChem CID 656668 — chemical identifiers
- DrugBank DB09231 — drug record
- FDA UNII 4G9T91JS7E — substance identity
- UniProt O95180 (CACNA1H) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.